ST Pharm Signs Supply Contract for Two Types of Phospholipids with North American Biotech Company
[Asia Economy Reporter Lee Jung-yoon] Dong-A Socio Holdings announced on the 3rd that its subsidiary ST Pharm has signed a supply contract with a global biotech company in the North American region for two types of core phospholipids used in LNP for mRNA vaccines (ionizable lipids and PEG lipids).
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
The contract amount is approximately 17.7 billion KRW, which corresponds to 10.7% of last year's sales.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
